WuXi partnerships at risk as lawmakers target Chinese ties to biopharma

The Biosecure Act would prohibit U.S. companies from working with “a biotechnology company of concern” and extending any contracts, but specifically seeks to limit ties with Chinese biotechs. The proposed bill calls out a handful of companies, including Complete Genomics and WuXi AppTec, a significant biopharma partner for many U.S. drugmakers.